Short-term response to anti-VEGF as indicator of visual prognosis in refractory age-related macular degeneration.

Background: Some patients with neovascular age-related macular degeneration (nAMD) respond insufficiently to anti-VEGF treatment despite maximal monthly intravitreal injections. Their short-term response between injections was investigated for extent and visual prognosis.

Subjects/methods: Monocentric retrospective observational study.